10 Speculative Analyst Stocks With Huge Potential Upside

GoPro Inc. (NASDAQ: GPRO) may be worth over $1 billion, but it is still highly speculative and in a niche business. Longbow Research raised the stock to Buy from Neutral on October 18, after the company sent out new product updates earlier in the week. Its shares had closed up 1.65% at $9.23 on Tuesday ahead of the call and were indicated to open up 4% at $9.60 on Wednesday. That being said, GoPro was only at $9.48 by week’s end. It has a 52-week range of $7.14 to $15.12, and its consensus target price was $9.89 ahead of the call but had moved up to $10.56 by the end of Friday’s session.

Halcon Resources Corp. (NYSE: HK) received two positive analyst calls this past week. Seaport Global Securities raised it to Buy from Neutral with an $8 price target (versus a $5.90 prior close) on October 17. Then it was raised to Buy from Accumulate at Johnson Rice on October 19. Halcon shares were last seen at $6.39, but headlines showed that shares had backed off their highs after an insider sold 1.65 million shares.

Lattice Semiconductor Corp. (NASDAQ: LSCC) was raised to Buy from Hold and the price target was raised to $7.00 from $6.50 at Jefferies on Wednesday. It should be noted that this call was against a $5.50 prior closing price, but shares were at $5.79 as trading ended on Friday. This was also a down-beaten name earlier in the year after its acquisition from China was blocked by CFIUS. Lattice Semiconductor has a 52-week range of $5.05 to $7.99.

Northern Dynasty Minerals Ltd. (NYSEAMERICAN: NAK) is about as speculative and controversial as you can get in gold and minerals stocks. It is a huge battleground stock, and most analysts would not dare touch this one. But it was started with a Buy rating and assigned a $2.50 price target at H.C. Wainwright (versus a $2.09 prior close) earlier in the week. The stock barely went up, and it was actually trading at $2.05 on last check. Its 52-week range is $0.67 to $3.45, and it is very thinly covered by analysts.

Oasis Petroleum Inc. (NYSE: OAS) was started as Overweight and assigned a $14.00 price target at Piper Jaffray on October 17, and the prior closing price was $8.67. Oasis shares were just at $8.71 on Friday’s close. The consensus target price is $12.52, and the 52-week range is $6.69 to $17.08. In an effort to show some caution: two other analyst calls stood out here. Goldman Sachs raised its rating to Neutral from Sell and Morgan Stanley maintained an Equal Weight rating and cut its target to $9 from $10 later in the week.

Stratasys Ltd. (NASDAQ: SSYS) may be a $1.2 billion company now, but it is in the 3D printing group of stocks that has gone from boom to bust for many fad-to-bubble investors. Susquehanna raised it to Positive from Neutral with a $31 price target on Friday. This was versus a prior closing price of $20.95, but the shares were up 10.8% on the day to $23.21 on Friday. Details of the call were not seen. Stratasys has a 52-week range of $16.37 to $30.88, and it had a consensus target price of $25.79. It still supposedly has a $39 street-high analyst target price, and the lowest analyst price target is $20.

Zynga Inc. (NASDAQ: ZNGA) was reiterated as Outperform with a $4.65 price target at Wedbush Securities on October 18. This call compared with a $3.84 prior closing price, and Zynga’s stock was only at $3.94 by Friday’s close. The firm noted strong revenues from CSR and Poker but wonders about the pipeline and thinks it may need a new hit to before the share price can rise meaningfully. That almost sounded more cautious than robust, and Zynga’s consensus target price is only $4.24. Its 52-week range is $2.40 to $4.02.

And beyond speculative is Immuron Ltd. (NASDAQ: IMRN). This tiny micro(scopic)-cap foreign stock has a market value of less than $20 million, so we wouldn’t normally cover this. H.C. Wainwright started the Australian biotech at Buy with a $15 price target on October 18. The prior close was $5.03 per American depositary share, and the stock traded at $5.25 by week’s end. The 52-week range is $4.47 to $10.00, and this outfit targets treatments for various gut medicated diseases. Be advised that 24/7 Wall St. had never heard of Immuron prior to this call.

24/7 Wall St. tracked an unusual exchange traded fund (ETF) launch this week. It was speculative in the sense that it is an artificial intelligence-powered stock-picking ETF using IBM’s Watson for its analysis and research. This ETF is called the AI Powered Equity ETF (NYSEMKT: AIEQ), and it joins BUZZ US Sentiment Leaders ETF (NYSEMKT: BUZ) in the AI theme for ETFs.

We have not yet adopted our year-forward analyst target views for any formal DJIA price targets in 2018. That still feels too soon considering earnings season isn’t over and considering that the holiday season and year-end changes have not been seen. Still, our first look at the data using the same methodology at the start of 2017 and prior years suggests that the Dow could be headed north of 25,000 a year from now.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.